Search Results - "Baker, Marshall S"

Using the NSQIP Pancreatic Demonstration Project to Derive a Modified Fistula Risk Score for Preoperative Risk Stratification in Patients Undergoing Pancreaticoduodenectomy by Kantor, Olga, MD, MS, Talamonti, Mark S., MD, FACS, Pitt, Henry A., MD, FACS, Vollmer, Charles M., MD, FACS, Riall, Taylor S., MD, PhD, FACS, Hall, Bruce L., MD, PhD, MBA, FACS, Wang, Chi-Hsiung, PhD, Baker, Marshall S., MD, MBA, FACS

“…Background The Fistula Risk Score (FRS) is a clinical tool developed from single-institutional data using primarily intraoperative factors to characterize the…”
Get full text

Association of Resident Independence With Short-term Clinical Outcome in Core General Surgery Procedures by Tonelli, Celsa M, Cohn, Tyler, Abdelsattar, Zaid, Luchette, Frederick A, Baker, Marshall S

“…Prior studies evaluating the effect of resident independence on operative outcome draw from case mixes that cross disciplines and overrepresent cases with low…”
Get more information

Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base by Sharpe, Susan M., MD, Talamonti, Mark S., MD, FACS, Wang, Chihsiung E., PhD, Prinz, Richard A., MD, FACS, Roggin, Kevin K., MD, FACS, Bentrem, David J., MD, FACS, Winchester, David J., MD, FACS, Marsh, Robert D.W., MD, Stocker, Susan J., CCRP, Baker, Marshall S., MD, MBA, FACS

“…Background There is considerable debate about the safety and clinical equivalence of laparoscopic pancreaticoduodenectomy (LPD) and open…”
Get full text

Trends, Cost, and Mortality From Sepsis After Trauma in the United States: An Evaluation of the National Inpatient Sample of Hospitalizations, 2012–2016 by Eguia, Emanuel, Bunn, Corinne, Kulshrestha, Sujay, Markossian, Talar, Durazo-Arvizu, Ramon, Baker, Marshall S., Gonzalez, Richard, Behzadi, Faraz, Churpek, Matthew, Joyce, Cara, Afshar, Majid

“…OBJECTIVES:Identification and outcomes in patients with sepsis have improved over the years, but little data are available in patients with trauma who develop…”
Get full text

The laparoscopic approach to distal pancreatectomy for ductal adenocarcinoma results in shorter lengths of stay without compromising oncologic outcomes by Sharpe, Susan M., M.D, Talamonti, Mark S., M.D, Wang, Edward, Ph.D, Bentrem, David J., M.D, Roggin, Kevin K., M.D, Prinz, Richard A., M.D, Marsh, Robert D.W., M.D, Stocker, Susan J., C.C.R.P, Winchester, David J., M.D, Baker, Marshall S., M.D., M.B.A

“…Abstract Background The oncologic equivalence of laparoscopic distal pancreatectomy (LDP) to open pancreatectomy (ODP) for ductal adenocarcinoma (DAC) is not…”
Get full text

The importance of the margin of resection and radiotherapy in retroperitoneal liposarcoma by Littau, Michael J., Kulshrestha, Sujay, Bunn, Corinne, Agnew, Sonya, Sweigert, Patrick, Luchette, Fred A., Baker, Marshall S.

“…Prior studies evaluating the impact of adjuvant or neoadjuvant radiotherapy on clinical outcomes in retroperitoneal liposarcoma have been underpowered. We…”
Get full text

Laparoscopic Distal Pancreatectomy for Cancer Provides Oncologic Outcomes and Overall Survival Identical to Open Distal Pancreatectomy by Kantor, Olga, Bryan, Darren S., Talamonti, Mark S., Lutfi, Waseem, Sharpe, Susan, Winchester, David J., Prinz, Richard A., Baker, Marshall S.

“…Background Laparoscopic distal pancreatectomy (LDP) has been shown to provide short-term clinical outcomes similar to open distal pancreatectomy (ODP) for…”
Get full text

Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma by Sur, Malini D., In, Haejin, Sharpe, Susan M., Baker, Marshall S., Weichselbaum, Ralph R., Talamonti, Mark S., Posner, Mitchell C.

“…Background Intrahepatic cholangiocarcinoma (ICC) is rare but is increasing in incidence. While hepatectomy can be curative, the benefit of adjuvant therapy…”
Get full text

A prospective single institution comparison of peri-operative outcomes for laparoscopic and open distal pancreatectomy by Baker, Marshall S., MD, MBA, Bentrem, David J., MD, Ujiki, Michael B., MD, Stocker, Susan, BA, LPN, Talamonti, Mark S., MD

“…Background Laparoscopic distal pancreatectomy (LP) is an emerging modality for managing benign and premalignant neoplasms of the pancreatic body and tail. The…”
Get full text

Surgical Management of Pancreatic Neuroendocrine Tumors by Liu, Jason B., MD, Baker, Marshall S., MD, MBA

“…Pancreatic neuroendocrine tumors (PNETs) are a rare, heterogeneous group of neoplasms infamous for their endocrinopathies. Up to 90% of PNETs, however, are…”
Get full text

Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors by Cherenfant, Jovenel, MD, Stocker, Susan J., CCRP, Gage, Mistry K., MPH, Du, Hongyan, MS, Thurow, Tiffany A., MD, Odeleye, Melanie, MD, Schimpke, Scott W., MD, Kaul, Karen L., MD, Hall, Curtis R., MD, Lamzabi, Ihab, MD, Gattuso, Paolo, MD, Winchester, David J., MD, Marsh, Robert W., MD, Roggin, Kevin K., MD, Bentrem, David J., MD, Baker, Marshall S., MD, Prinz, Richard A., MD, Talamonti, Mark S., MD

“…Purpose The biologic potential of nonfunctioning pancreatic neuroendocrine tumors (PNETs) is highly variable and difficult to predict before resection. This…”
Get full text

Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head by Lutfi, Waseem, BS, Talamonti, Mark S., MD, Kantor, Olga, MD, Wang, Chi-Hsiung, PhD, Liederbach, Erik, BS, Stocker, Susan J., LPN, Bentrem, David J., MD, Roggin, Kevin K., MD, Winchester, David J., MD, Marsh, Robert, MD, Prinz, Richard A., MD, Baker, Marshall S., MD

“…Background The value of neoadjuvant chemotherapy in the treatment of early stage pancreatic cancer is not yet clear. Methods We evaluated patients from the…”
Get full text

Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study by Marsh, Robert, Talamonti, Mark S., Baker, Marshall S., Posner, Mitchell, Roggin, Kevin, Matthews, Jeffrey, Catenacci, Daniel, Kozloff, Mark, Polite, Blase, Britto, Michele, Wang, Chi, Kindler, Hedy

“…Background and Objectives Surgery followed by gemcitabine and/or a fluoropyrimidine is standard therapy for resectable PDAC. mFOLFIRINOX (oxaliplatin 85 mg/m2,…”
Get full text

Using a modification of the Clavien-Dindo system accounting for readmissions and multiple interventions: Defining quality for pancreaticoduodenectomy by Baker, Marshall S., Sherman, Karen L., Stocker, Susan J., Hayman, Amanda V., Bentrem, David J., Prinz, Richard A., Talamonti, Mark S.

“…Background The Clavien‐Dindo system (CD) does not change the grade assigned a complication when multiple readmissions or interventions are required to manage a…”
Get full text

Is positive histologic surgical margin associated with overall survival in patients with resectable gallbladder cancer? by Littau, Michael J, Kulshrestha, Sujay, Bunn, Corinne, Kim, Preston, Luchette, Fred A., Baker, Marshall S.

“…Achieving microscopically negative (R0) surgical margins in gallbladder cancer often requires a partial hepatectomy with associated risk of morbidity and…”
Get full text

Elements of the care environment influence coronary artery bypass surgery readmission by Rogers, Michael P., Cousin-Peterson, Evelena, Barry, Tara M., Baker, Marshall S., Kuo, Paul C., Janjua, Haroon M.

“…Coronary artery bypass grafting 30-day unplanned readmission is a focus for the CMS Hospital Readmissions Reduction Program. Awareness of the critical elements…”
Get full text

External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma by Kantor, Olga, MD, MS, Talamonti, Mark S., MD, Lutfi, Waseem, BS, Wang, Chi-Hsiung, PhD, Winchester, David J., MD, Marsh, Robert, MD, Prinz, Richard A., MD, Baker, Marshall S., MD, MBA, FACS

“…Background The absolute benefit of adjuvant external beam radiation therapy after a margin-negative resection in early stage pancreatic cancer has not been…”
Get full text

Adding days spent in readmission to the initial postoperative length of stay limits the perceived benefit of laparoscopic distal pancreatectomy when compared with open distal pancreatectomy by Baker, Marshall S., M.D., M.B.A, Bentrem, David J., M.D, Ujiki, Michael B., M.D, Stocker, Susan, B.A., L.P.N, Talamonti, Mark S., M.D

“…Abstract Background Published comparisons of laparoscopic (laparoscopic distal pancreatectomy [LDP]) to open distal pancreatectomy (ODP) identify improved…”
Get full text

Esophagectomy in Locally Advanced Adenocarcinoma: Short-Term Postoperative Outcomes and Supplemental Report of Propensity Match Results: In Reply to Li and colleagues by Baker, Marshall S, Kramer, Sarah P

Get full text

Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors by Cherenfant, Jovenel, MD, Talamonti, Mark S., MD, Hall, Curtis R., MD, Thurow, Tiffany A., MD, Gage, Mistry K., MS, Stocker, Susan J., CCRP, Lapin, Brittany, MS, Wang, Edward, PhD, Silverstein, Jonathan C., MD, Mangold, Kathy, PhD, Odeleye, Melanie, MD, Kaul, Karen L., MD, Lamzabi, Ihab, MD, Gattuso, Paolo, MD, Winchester, David J., MD, Marsh, Robert W., MD, Roggin, Kevin K., MD, Bentrem, David J., MD, Baker, Marshall S., MD, Prinz, Richard A., MD

“…Background This study compares the predictability of 5 tumor markers for distant metastasis and mortality in pancreatic neuroendocrine tumors (PNETs). Methods…”
Get full text